Dr Hafyz is a lecturer at Emergency Medicine Academic Unit in Faculty of Medicine, Universiti Malaya. Having earned his degree from Royal College of Surgeon in Ireland in 2010, he later completed his Clinical Master in Emergency Medicine in 2019 through Universiti Malaya Trainee Lecturer program. Awarded for his service excellence by UMMC in 2014 and Universiti Malaya in 2023, he currently oversees Paediatric Emergency at UMMC. With a keen interest in paediatric emergencies and emergency cardiac care, he has contributed to several studies, including the development of a Covid test kit by Seegene, Korea, and a study on emergency and trauma service in Malaysia by TXP Medical, Japan. Dr Hafyz shares his expertise on CPR on Berita TV Al-Hijrah and instructs courses in basic life support, paediatric advanced life support and advanced cardiac life support. He also proudly represents Universiti Malaya in the MAKSWIP badminton tournament.

Amira Firdaus is an Associate Professor at Universiti Malaya’s Department of Media and Communication Studies, Faculty of Arts & Social Sciences. Amira's core expertise is Positive/Constructive Communication with practical and conceptual applications across three fields: Communication, Higher Education, and Positive Psychology. Within these areas, Amira's interest in positive/constructive communication is implicitly integrated into her work in digital ethnography, e-learning, constructive journalism, positive education, positive organizations, and active ageing.   Amira's current multidisciplinary foci include: Adult ADHD/ADD media and communication; faculty wellbeing & happiness; online learning instructional design & communication; empathetic/inclusive instructional communication. Amira recently completed her term as Deputy Director for Professional Development / Head for Teaching & Learning at UM's Academic Development & Enhancement Centre (ADEC) (2014-2022). Amira holds a PhD in communication from the University of Melbourne. *Students seeking PhD or MA supervision with Amira Firdaus are kindly encouraged to email amira_firdaus@um.edu.my before submitting your application online.  ______________________________________________________________________    

Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.